SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Highstreet

Highstreet is seeing intense community engagement as investors debate the potential for a technical short squeeze following a significant recent price decline. Traders are actively monitoring whale accumulation and technical indicators while highlighting the token's low supply and history of volatile price swings as reasons for their bullish interest.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is generating significant buzz as investors track tightening supply fundamentals and upward momentum in lithium futures, with many pointing to a potential market deficit that could catalyze a strong multi-year recovery. The community remains focused on the company's operational scaling and capacity expansion, while active debates persist regarding the balance between institutional analyst confidence and the risks posed by short-seller reports and regulatory headlines.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining significant community attention as investors draw parallels to recent high-profile biotech acquisitions, fueling speculation about its potential as a buyout target due to its de-risked clinical pipeline and substantial cash position. Shareholders are actively discussing positive trial data milestones, the strategic impact of the upcoming Annual Urological Association presentation, and the potential for a short squeeze as they anticipate future BLA filings.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is currently the center of intense debate among traders as they monitor flight test data and potential legal milestones while weighing the company's progress against competitors in the eVTOL space. The community remains sharply divided between those tracking technical indicators and institutional buying for a long-term turnaround, and those expressing skepticism over production timelines and management.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

The Walt Disney Co. is trending as investors monitor the upcoming leadership transition to CEO Josh D'Amaro alongside community anticipation for recent theatrical releases and the performance of its streaming bundle. Traders are actively debating the stock's valuation as a long-term play, while sentiment remains polarized over the company's content strategy and its ability to return to growth.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin Corp is experiencing a sharp surge in investor optimism following preliminary financial reports that show the company has achieved positive cash flow ahead of schedule and expanded its cash reserves to over $300 million. This momentum is further fueled by expectations surrounding management's upcoming meetings at the J.P. Morgan Healthcare Conference, where the community is actively speculating on potential strategic partnerships or acquisition interest as the company pivots toward a leaner, royalty-focused operational model.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is gaining momentum as investors react to potential breakthroughs in regulatory clarity and institutional adoption, with a highly active community debating its long-term potential as a bridge currency. While some traders are focused on short-term price patterns and the prospect of a short squeeze, many are looking ahead to future financial integration milestones.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render is trending as investors react to the ongoing RenderCon event, which has highlighted key technical integrations and a strengthening bullish narrative around decentralized GPU compute demand. While some community members are closely monitoring potential volatility during the event, many are focused on the long-term utility of the network for AI and spatial computing infrastructure.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin (LTC) is currently a flashpoint for debate, with the community polarized between those betting on long-term utility through new developments like LitVM and skeptics who criticize its prolonged underperformance compared to other assets. While some traders are focused on short-term technical patterns and potential whale accumulation, others are actively warning of its perceived failure to reclaim momentum in the broader crypto market.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as the community debates a potential decoupling from COMEX silver prices, fueled by reports of significant premiums in the Shanghai market and active discussions regarding supply shortages and global production constraints. Traders are intensely focused on short-term technical volatility and mining-specific news, with many analysts highlighting the stock as a high-torque play on the broader precious metals sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JPMorgan Chase & Co. Buys 196,079 Shares of Korro Bio, Inc. $KRRO

JPMorgan Chase & Co. grew its stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 6,185.5% during the third quarter, according to the company in its most recent filing with the Securities and...

Korro Bio, Inc. (NASDAQ:KRRO) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have assigned a hold rati...

Korro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook

Korro Bio stock rises after earnings as analysts upgrade outlook, highlight new drug candidate, and long-term growth plans.read more...

Korro Bio (NASDAQ:KRRO) Rating Increased to Outperform at Raymond James Financial

Raymond James Financial upgraded Korro Bio from a "market perform" rating to an "outperform" rating and set a $23.00 price target for the company in a research report on Friday...

Insider Buying: Korro Bio (NASDAQ:KRRO) Major Shareholder Buys 207,100 Shares of Stock

Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Scott Sandell acquired 207,100 shares of Korro Bio stock in a transaction that occurred on Tuesday, March 10th. The shares were...

Korro Bio (NASDAQ:KRRO) Major Shareholder Buys $2,300,881.00 in Stock

Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Rick Yang purchased 207,100 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was bought at an average...

Insider Buying: Korro Bio (NASDAQ:KRRO) Major Shareholder Purchases 207,100 Shares of Stock

Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Anthony Jr. Florence acquired 207,100 shares of Korro Bio stock in a transaction on Tuesday, March 10th. The shares were bought at an...

Korro Bio (NASDAQ:KRRO) Major Shareholder Paul Edward Walker Buys 207,100 Shares

Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Paul Edward Walker acquired 207,100 shares of Korro Bio stock in a transaction dated Tuesday, March 10th. The shares were purchased...

Insider Buying: Korro Bio (NASDAQ:KRRO) Major Shareholder Acquires 207,100 Shares of Stock

Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Mohamad Makhzoumi bought 207,100 shares of the business's stock in a transaction dated Tuesday, March 10th. The stock was acquired at...

Edward Mathers Acquires 207,100 Shares of Korro Bio (NASDAQ:KRRO) Stock

Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Edward Mathers purchased 207,100 shares of the stock in a transaction that occurred on Tuesday, March 10th. The stock was acquired at...

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

KRRO
Korro Bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KRRO News

KRROKorro Bio Inc